Kidney Transplantation Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Empagliflozin Treatment in Kidney Transplant Recipients
Conditions: Kidney Transplant; Type 2 Diabetes Intervention: Drug: Empagliflozin Sponsors: VA Office of Research and Development; Iowa City VA Health Care System; VA Pittsburgh Healthcare System; Nashville VA Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
ddcfDNA in Kidney Transplant Recipients
Condition: Kidney Transplant Rejection Intervention: Genetic: AlloSeq cfDNA Sponsors: Seoul National University Hospital; Samsung Medical Center; Asan Medical Center; Severance Hospital; Korea University Anam Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
Empagliflozin Treatment in Kidney Transplant Recipients
Conditions: Kidney Transplant; Type 2 Diabetes Intervention: Drug: Empagliflozin Sponsors: VA Office of Research and Development; Iowa City VA Health Care System; VA Pittsburgh Healthcare System; Nashville VA Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
ddcfDNA in Kidney Transplant Recipients
Condition: Kidney Transplant Rejection Intervention: Genetic: AlloSeq cfDNA Sponsors: Seoul National University Hospital; Samsung Medical Center; Asan Medical Center; Severance Hospital; Korea University Anam Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
Empagliflozin Treatment in Kidney Transplant Recipients
Conditions: Kidney Transplant; Type 2 Diabetes Intervention: Drug: Empagliflozin Sponsors: VA Office of Research and Development; Iowa City VA Health Care System; VA Pittsburgh Healthcare System; Nashville VA Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
ddcfDNA in Kidney Transplant Recipients
Condition: Kidney Transplant Rejection Intervention: Genetic: AlloSeq cfDNA Sponsors: Seoul National University Hospital; Samsung Medical Center; Asan Medical Center; Severance Hospital; Korea University Anam Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
Empagliflozin Treatment in Kidney Transplant Recipients
Conditions: Kidney Transplant; Type 2 Diabetes Intervention: Drug: Empagliflozin Sponsors: VA Office of Research and Development; Iowa City VA Health Care System; VA Pittsburgh Healthcare System; Nashville VA Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
ddcfDNA in Kidney Transplant Recipients
Condition: Kidney Transplant Rejection Intervention: Genetic: AlloSeq cfDNA Sponsors: Seoul National University Hospital; Samsung Medical Center; Asan Medical Center; Severance Hospital; Korea University Anam Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
Empagliflozin Treatment in Kidney Transplant Recipients
Conditions: Kidney Transplant; Type 2 Diabetes Intervention: Drug: Empagliflozin Sponsors: VA Office of Research and Development; Iowa City VA Health Care System; VA Pittsburgh Healthcare System; Nashville VA Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
ddcfDNA in Kidney Transplant Recipients
Condition: Kidney Transplant Rejection Intervention: Genetic: AlloSeq cfDNA Sponsors: Seoul National University Hospital; Samsung Medical Center; Asan Medical Center; Severance Hospital; Korea University Anam Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
Empagliflozin Treatment in Kidney Transplant Recipients
Conditions: Kidney Transplant; Type 2 Diabetes Intervention: Drug: Empagliflozin Sponsors: VA Office of Research and Development; Iowa City VA Health Care System; VA Pittsburgh Healthcare System; Nashville VA Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
ddcfDNA in Kidney Transplant Recipients
Condition: Kidney Transplant Rejection Intervention: Genetic: AlloSeq cfDNA Sponsors: Seoul National University Hospital; Samsung Medical Center; Asan Medical Center; Severance Hospital; Korea University Anam Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
Empagliflozin Treatment in Kidney Transplant Recipients
Conditions: Kidney Transplant; Type 2 Diabetes Intervention: Drug: Empagliflozin Sponsors: VA Office of Research and Development; Iowa City VA Health Care System; VA Pittsburgh Healthcare System; Nashville VA Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
ddcfDNA in Kidney Transplant Recipients
Condition: Kidney Transplant Rejection Intervention: Genetic: AlloSeq cfDNA Sponsors: Seoul National University Hospital; Samsung Medical Center; Asan Medical Center; Severance Hospital; Korea University Anam Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
Empagliflozin Treatment in Kidney Transplant Recipients
Conditions: Kidney Transplant; Type 2 Diabetes Intervention: Drug: Empagliflozin Sponsors: VA Office of Research and Development; Iowa City VA Health Care System; VA Pittsburgh Healthcare System; Nashville VA Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials